There's a number of questions that we'll be wanting to ask. What reassurances can the Government give for the vaccine without the Pfizer data? So I've mentioned international studies offshore. What reassurances does the Government have that non-Pfizer data provides efficacy and/or the side effect profiles we might want to know about? How many people will be protected over the month or two before Pfizer does have that data? So let's say it's six weeks, then. Are we sure that the benefits to the vulnerable outweigh waiting for that six weeks and having that data moving through Medsafe? I think it's a good question to ask how many people might be protected.